Scynexis (SCYX) Misses Q1 Expectations

Scynexis (NASDAQ: SCYX) reported Q1 EPS of ($0.75), $0.32 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $2.31 million versus the consensus estimate of $4.2 million.

Cash and cash equivalents totaled $27.6 million as of March 31, 2015.

For earnings history and earnings-related data on Scynexis (SCYX) click here.

You May Also Be Interested In

• SCYNEXIS (SCYX) PT Raised to $33 at Guggenheim
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c